Passage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference

Passage Bio

PHILADELPHIA, PA — Passage Bio, Inc. (NASDAQ: PASG) announced that William Chou, M.D., president and chief executive officer, will participate in a fireside chat at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference on Monday, November 6, 2023, at 2:30 p.m. ET.

A live webcast of the event will be available on the Investors & Media section of Passage Bio’s website at investors.passagebio.com. A replay of the presentation will be available for 30 days following the event.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.

READ:  TELA Bio Set to Unveil Innovations at Piper Sandler's Premier Healthcare Conference!